Startups
Edit
https://www.osteoporosis.foundation/
International Osteoporosis Foundation
TrustedLast activity: 16.06.2026
Active
The International Osteoporosis Foundation (IOF) is a registered not-for-profit, non-governmental foundation in Nyon, Switzerland. IOF functions as a global alliance of patient, medical and research societies, scientists, health care professionals, and international companies concerned about bone health.
Overview
Location
Switzerland, Vaud, Nyon
Employees
11-50
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 19, 2025 | European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively | SHANGHAI and JERSEY CITY, N.J., Sept. 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for BILDYOS® (denosumab) injec... |
| May 22, 2024 | Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe | Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines Xgeva® and Prolia® EC approval based on ... |
| Feb 24, 2023 | WHO and ESCEO announce collaborative agreement to benefit global osteoporosis and fracture prevention | WHO and ESCEO sign agreement on February 23, 2023 in Geneva, Switzerland The collaboration will develop a strategic roadmap on bone health and aging, and advocate for a public health strategy to prevent fractures among older people. This co... |
| Oct 20, 2022 | On World Osteoporosis Day, take five steps to better bone health | NYON, Switzerland, Oct. 20, 2022 /PRNewswire/ -- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis preventio... |
| Sep 19, 2022 | Sandoz announces further progress on its biosimilar pipeline, with release of positive results for denosumab integrated Phase I/III clinical trial | ROSALIA study met primary endpoints, confirming proposed biosimilar denosumab matches reference product in terms of pharmacokinetics, pharmacodynamics, efficacy, safety and immunogenicity in postmenopausal women with osteoporosis Osteoporos... |
| Jul 22, 2022 | Зачем нужно иногда вставать из-за компьютера? Часть первая | Программисты люди усидчивые, часов в сутках и так не хватает для решения любимых задач, а с современными on-line возможностями, когда все, что нужно и просто хочется, доставляется домой и можно устроить домашний офис комфортабельнее, чем оф... |
| Oct 20, 2021 | Action for bone health is needed now more than ever, urges IOF | NYON, Switzerland, Oct. 20, 2021 /PRNewswire/ -- A backlog in osteoporosis assessments, treatment delays, and sedentary indoor lifestyles: these are just several ways in which the Covid-19 pandemic has impacted bone health and disrupted glo... |
| May 17, 2021 | This Medtech Company Invented A Solution To Treat Bone Health Conditions Affecting 54 Million Americans And Costing The Healthcare System $19 Billion Annually | Laura Yecies, CEO of Bone Health Technologies, holding the OsteoBoost Vibration BeltBHT |
| Black and brown people struggle to get enough vitamin D—what to know about the vital nutrient and when you might need a supplement | A 2017 study showed an increase in vitamin D deficiency diagnoses — which researchers linked to an uptick in vitamin D test requests, indicating a rising interest in the nutrient. As more and more people become aware of the effects of vitam... |
Reviews 0
FAQ about International Osteoporosis Foundation
What has the press written about International Osteoporosis Foundation?
Parsers VC has collected 10 articles mentioning International Osteoporosis Foundation, among them “European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosum...” (Sep 19, 2025) and “Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe” (May 22, 2024).
Is International Osteoporosis Foundation still active?
Yes, International Osteoporosis Foundation is active; its latest activity on Parsers VC dates from Jun 16, 2026.